Helsinn and Mundipharma China Pharmaceutical collectively announces the launching of the ALOXI IV in China along with a Co-Detailing teamwork in Shanghai

Helsinn and Mundipharma China Pharmaceutical together announce the launch of ALOXI® IV in China and a Co-Detailing collaboration in Shanghai Lugano, Switzerland, and Beijing, China, May 9, 2019: Helsinn Group, a Swiss pharmaceutical group focused on building quality cancer care products, and…